Tuesday, January 13, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Intel Shares Surge on Potential Apple Partnership

Dieter Jaworski by Dieter Jaworski
November 29, 2025
in Analysis, Mergers & Acquisitions, Nasdaq, Semiconductors, Tech & Software
0
Intel Stock
0
SHARES
35
VIEWS
Share on FacebookShare on Twitter

A seismic shift may be underway for the US semiconductor giant Intel. Following a prolonged struggle to secure significant foundry contracts, speculative reports of a potential alliance with Apple have ignited a powerful rally in its stock. The market’s enthusiastic response raises a pivotal question: does this signal Intel’s decisive breakthrough against formidable Asian competitors, or is the current optimism premature?

Market Reaction and Performance

Trading activity on the abbreviated Black Friday session was exceptionally volatile. Intel’s stock experienced a dramatic surge, closing at €35.16 after an impressive single-day gain of 11.91 percent. Trading volumes exploded, far exceeding the daily average.

This powerful upswing represents the culmination of a substantial recovery already in progress. Since the beginning of the year, Intel shares have recorded gains exceeding 78 percent, bringing them close to their 52-week high of €35.66.

The Analyst Report Fueling Optimism

The catalyst for this buying frenzy is an analysis from TF International Securities’ renowned market expert, Ming-Chi Kuo. His research indicates a strong probability that Intel will become a manufacturing partner for Apple’s proprietary processors, specifically those in its M-series.

Should investors sell immediately? Or is it worth buying Intel?

Should this materialize, it would mark a significant industry inflection point. Apple has historically relied almost exclusively on Taiwan Semiconductor Manufacturing Company (TSMC) for its advanced chips. The mere consideration of Intel as a “second source” for its production needs is sending shockwaves through the technology sector.

Strategic Implications of a Landmark Deal

The potential agreement carries profound strategic weight and could redefine Intel’s future trajectory. Key details under consideration include:

  • Technology: Reports indicate Apple has already received the design kit for Intel’s cutting-edge “18A” manufacturing process.
  • Timeline: Volume production is anticipated to commence in either the second or third quarter of 2027.
  • Scale: The deal could encompass an estimated 15 to 20 million units annually, primarily for entry-level models of devices like the MacBook Air and iPad Pro.

For Intel, securing Apple as a client would serve as the ultimate validation of its ambitious “IDM 2.0” strategy to open its fabrication plants to external customers. As one of the most demanding customers globally, a partnership with Apple would send an undeniable signal of technical competence to the broader market. Furthermore, it aligns perfectly with geopolitical trends favoring a “Made in USA” supply chain.

Conclusion: A Shift in Sentiment

Market sentiment toward Intel has transformed abruptly. While any potential revenue from an Apple partnership remains at least two years away, the symbolic value of this potential endorsement currently outweighs concerns over ongoing legal disputes with competitors. Investor focus is now firmly fixed on the revenue potential of the Apple pipeline. The market awaits an official confirmation with bated breath, and until then, Intel shares are likely to remain highly volatile.

Ad

Intel Stock: Buy or Sell?! New Intel Analysis from January 13 delivers the answer:

The latest Intel figures speak for themselves: Urgent action needed for Intel investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 13.

Intel: Buy or sell? Read more here...

Tags: Intel
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Almonty Stock
Commodities

Almonty’s Strategic Pivot: From Defense to Fusion Energy

January 13, 2026
CureVac Stock
Mergers & Acquisitions

CureVac’s Stock Journey Concludes Following BioNTech Acquisition

January 13, 2026
MSCI World ETF Stock
Analysis

A Deep Dive into the iShares MSCI World ETF’s Performance and Strategy

January 13, 2026
Next Post
Nvidia Stock

Nvidia Shares Face Pressure as Meta Explores Google's AI Chips

Unitedhealth Stock

UnitedHealth Shares Plunge as Medical Costs Spiral

Marvell Technology Stock

Marvell Technology's Tuesday Earnings: A Critical Juncture for the AI Chip Stock

Recommended

Blackbaud Stock

Blackbaud Emerges as Quiet Performer in Non-Profit Software Sector

5 months ago
Warner Bros. Discovery (A) Stock

Analysts Sound Caution on Warner Bros. Discovery Shares Despite Strong Performance

4 months ago
Summit Hotel Properties Stock

Summit Hotel Properties Maintains Dividend Amid Challenging Quarter

5 months ago
EOG stock news

SG Americas Securities LLC Strengthens Portfolio with Strategic Investment in Coastal Financial Co.

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

A Deep Dive into the iShares MSCI World ETF’s Performance and Strategy

Pfizer’s Strategic Shift Weighs on Investor Sentiment

Analyst Downgrade Overshadows PayPal’s Strategic Moves

Ethereum’s Quiet Consolidation Masks a Strengthening Foundation

Fiserv Embarks on Strategic AI Push Amid Leadership Reshuffle

Alphabet Reaches Historic Valuation Milestone on Dual Strategic Wins

Trending

Almonty Stock
Commodities

Almonty’s Strategic Pivot: From Defense to Fusion Energy

by Felix Baarz
January 13, 2026
0

Investor attention is turning toward Almonty Industries Inc. as the tungsten producer becomes linked to two powerful...

Novo Nordisk Stock

Novo Nordisk Bets on Oral Wegovy to Expand Weight-Loss Market Reach

January 13, 2026
CureVac Stock

CureVac’s Stock Journey Concludes Following BioNTech Acquisition

January 13, 2026
MSCI World ETF Stock

A Deep Dive into the iShares MSCI World ETF’s Performance and Strategy

January 13, 2026
Pfizer Stock

Pfizer’s Strategic Shift Weighs on Investor Sentiment

January 13, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Almonty’s Strategic Pivot: From Defense to Fusion Energy
  • Novo Nordisk Bets on Oral Wegovy to Expand Weight-Loss Market Reach
  • CureVac’s Stock Journey Concludes Following BioNTech Acquisition

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com